Glycemic Control in Hospitalized Patients with Diabetes Receiving Corticosteroids Using a Neutral Protamine Hagedorn Insulin Protocol: A Randomized Clinical Trial

Add-on treatment with intermediate-acting insulin versus sliding-scale insulin for patients with type 2 diabetes or insulin resistance during cyclic glucocorticoid-containing antineoplastic chemotherapy: a randomized crossover study

(2016) M. C. Gerards et al.   DIABETES OBESITY & METABOLISM

HOSPITAL INSULIN PROTOCOL AIMS FOR GLUCOSE CONTROL IN GLUCOCORTICOID-INDUCED HYPERGLYCEMIA

(2016) Bethany Grommesh et al.   Endocrine Practice

Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease

(2015) María S. Ruiz de Adana et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Efficacy of a basal bolus insulin protocol to treat prednisolone-induced hyperglycaemia in hospitalised patients

(2015) M. G. Burt et al.   INTERNAL MEDICINE JOURNAL

Examination of Implementation of Intravenous and Subcutaneous Insulin Protocols and Glycemic Control in Heart Transplant Patients

(2013) Amisha Wallia et al.   Endocrine Practice

Glucocorticoid-induced hyperglycemia (糖皮质激素诱导的高血糖)

(2013) Antonio Perez et al.   Journal of Diabetes

Continuous Monitoring of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD

(2011) Morton G. Burt et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pilot study of using neutral protamine hagedorn insulin to counteract the effect of methylprednisolone in hospitalized patients with diabetes

(2011) Stacey A. Seggelke et al.   Journal of Hospital Medicine

Posttransplant Hyperglycemia is Associated With Increased Risk of Liver Allograft Rejection

(2010) Amisha Wallia et al.   TRANSPLANTATION

Glucocorticoid-Induced Hyperglycemia

(2009) John Clore et al.   Endocrine Practice

Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?

(2009) D. H. van Raalte et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION